Menu Menu


PRTG Financials       Clear


PRTG        0001095435    
Filing Date Form Type Description Document
2015-06-25 6-K COMPLETION OF PRIVATE PLACEMENT View Document
2015-06-17 6-K PORTAGE CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT View Document
2015-05-19 6-K PROPOSED PRIVATE PLACEMENT View Document
2015-04-22 6-K BIOHAVEN UPDATE View Document
2015-04-21 6-K PPL UPDATE View Document
2015-04-16 6-K PORTAGE ATTENDING INVESTOR MASTER SHOW IN UK View Document
2015-04-01 6-K BIOHAVEN UPDATE RE INVENTIV View Document
2015-03-25 6-K BIOHAVEN UPDATE View Document
2015-03-17 S-8 2013 OPTION PLAN REGISTRATION View Document
2015-02-18 6-K FINANCIALSTATEMENTSFEB15 View Document
2015-02-12 SC 13D/A SC 13D/A View Document
2014-12-18 6-K BIOHAVEN UPDATE View Document
2014-12-16 6-K PPL UPDATE View Document
2014-11-28 6-K PORTAGEFINANCIALS2Q15 View Document
2014-10-16 6-K CLOSURE OF PRIVATE PLACEMENT View Document
2014-10-08 6-K APPOINTMENT OF ADDITIONAL CONSULTANTS View Document
2014-09-29 6-K CONVERSION OF DEBTS INTO EQUITY View Document
2014-09-24 6-K PORTAGE APPOINTS NEW CONSULTANTS View Document
2014-08-13 6-K QUARTERLY FINANCIALS View Document
2014-08-06 6-K BIOHAVEN PATENT APPROVAL View Document
2014-07-31 20-F ANNUAL REPORT View Document
2014-07-14 6-K SUCCESSFUL VALIDATION OF PEPTIDE PLATFORM TECHNOLOGY View Document
2014-05-21 424B3 View Document
2014-05-21 424B3 View Document
2014-05-16 6-K PORTAGE SIGNS A COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH US NATIONA View Document
2014-05-09 424B3 View Document
2014-05-09 424B3 View Document
2014-05-08 6-K View Document
2014-05-06 424B3 View Document
2014-05-06 424B3 View Document
2014-05-05 6-K PORTAGE?S BIOHAVEN ISSUED NOTICE OF ALLOWANCE: GLUTAMATE AGENTS IN THE TREATMENT View Document
2014-04-14 424B3 View Document
2014-04-14 424B3 View Document
2014-04-11 6-K PORTAGE PROVIDES UPDATES View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-25 6-K PORTAGE REPORTS THIRD QUARTER FINANCIAL RESULTS View Document
2014-02-25 6-K PORTAGE BIOTECH INC. THREE AND NINE MONTHS ENDED DECEMBER 31, 2013 View Document
2014-02-12 424B3 View Document
2014-02-12 424B3 View Document
2014-02-11 6-K FORM 6-K COVER SHEET View Document
2014-01-31 SC 13D/A FORM SC 13D/A View Document
2014-01-29 SC 13G/A FORM SC 13G/A View Document
2014-01-07 424B3 View Document
2014-01-07 424B3 View Document
2014-01-07 6-K PORTAGE ACQUIRES MAJORITY INTEREST IN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LI View Document
2013-12-23 424B3 View Document
2013-12-23 424B3 View Document
2013-12-19 S-8 FORM S-8 View Document
2013-12-18 424B3 View Document
2013-12-18 424B3 View Document
2013-12-17 6-K PORTAGE LAUNCHES NEW WEBSITE AND PROVIDES UPDATE ON ITS R&D ACTIVITIES View Document
2013-12-17 424B3 View Document
2013-12-17 424B3 View Document
2013-11-26 6-K PORTAGE BIOTECH INC. THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2013 View Document
2013-11-13 424B3 View Document
2013-11-13 424B3 View Document
2013-11-12 6-K PORTAGE APPOINTS SCIENTIFIC ADVISORY BOARD View Document
2013-10-29 424B3 View Document
2013-10-29 424B3 View Document
2013-10-28 6-K/A AMENDED PRESS RELEASE DATED OCTOBER 25, 2013 View Document
2013-10-28 424B3 View Document
2013-10-28 424B3 View Document
2013-10-25 6-K PORTAGE ANNOUNCES LISTING ON CANADIAN NATIONAL STOCK EXCHANGE View Document
2013-08-30 424B3 View Document
2013-08-30 424B3 View Document
2013-08-29 6-K PORTAGE BIOTECH INC. FINANCIAL STATEMENTS AND MD&A FOR THE QUARTER ENDED JUNE 30 View Document
2013-08-23 424B3 View Document
2013-08-23 424B3 View Document
2013-08-22 6-K PORTAGE BIOTECH INC?S NAME CHANGE AND NEW TRADING SYMBOL APPROVED BY FINRA View Document
2013-08-07 424B3 View Document
2013-08-07 424B3 View Document
2013-08-01 6-K BONTAN CHANGES ITS NAME TO PORTAGE BIOTECH INC. AND JURISDICTION TO BVI View Document
2013-07-31 424B3 View Document
2013-07-31 424B3 View Document
2013-07-25 20-F BONTAN CORPORATION FORM 20-F View Document
2013-06-06 424B3 View Document
2013-06-06 424B3 View Document
2013-06-05 6-K SHARE EXCHANGE AGREEMENT View Document
2013-06-05 424B3 View Document
2013-06-05 424B3 View Document
2013-06-04 6-K BONTAN CLOSES PORTAGE PHARMA LIMITED ACQUISITION View Document
2013-05-14 424B3 View Document
2013-05-14 424B3 View Document
2013-05-13 6-K BONTAN PROVIDES UPDATE ON LETTER OF INTENT WITH PORTAGE PHARMA LTD. View Document
2013-04-11 424B3 View Document
2013-04-11 424B3 View Document
2013-04-10 6-K BONTAN INCORPORATES A SUBSIDIARY IN THE BRITISH VIRGIN ISLANDS View Document
2013-03-28 424B3 View Document
2013-03-28 424B3 View Document
2013-03-27 6-K BONTAN SIGNS LETTER OF INTENT View Document
2013-02-27 424B3 View Document
2013-02-27 424B3 View Document
2013-02-26 6-K BONTAN FINANCIAL STATEMENTS AND MD&A FOR THE QUARTER ENDED DECEMBER 31, 2012 View Document
2013-02-11 424B3 View Document
2013-02-11 424B3 View Document
2013-02-07 6-K BONTAN AGREES TO THE GENERAL TERMS IN A LETTER OF INTENT View Document
2013-01-23 UPLOAD View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas